Creating smarter ways to fight bacteria
Leading the advancement of technologies and products
that break up biofilms and destroy bacteria.
2022 Video Blog Series
As part of our commitment to communicate more frequently with our investors in 2022, Kane Biotech Inc. introduces a new video blog series, with each video focused on one important topic that is driving our business forward.
The study of biofilms has increased significantly in recent years due to the growing awareness of the pervasiveness and impact of biofilms on human and animal health, as well as natural and industrial systems.
Biofilms are estimated to be responsible for 80% of all human bacterial infections, costing billions of dollars each year.
The companion pet market in North America has grown to an estimated $62 billion in sales per year, with the oral health care segment growing rapidly at approximately 20%.
The rapidly expanding industry for biomedical devices is estimated at $180 billion, yet it continues to suffer from microbial colonization. Microbial infections can develop on all medical devices and hard surfaces.
For over 10 years Kane Biotech’s R+D division has been developing new technologies and innovations leading to 81 patents and patents pending in biotechnology focusing primarily on biofilm.
Patents and Patents Pending